Ablynx, Merck in Nanobodies deal

Ablynx N.V. (Euronext:ABLX) partnered with Merck & Co. Inc. (NYSE:MRK) to develop and commercialize Ablynx's Nanobodies targeting an undisclosed voltage-gated ion channel. The deal includes an option ...